We also analyzed an independent group of 12 IDH-mutant astrocytomas and 18 IDH-wild-type glioblastomas which were wild-type for MMR genes at the first resection but developed an MMR mutation at tumor recurrence. This evidence concerns the gene IDH1 and glioblastoma.